Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/30/19 → 09/30/21 |
Funding
- Eisai Incorporated: $7,250.00
Eisai APD356-A001: A 52-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Belviq XR in Conjunction with Lifestyle Modification for Weight Loss in Obese Adolescents Age 12-17 Years
- Bethin, Kathleen (PI)
Project: Research